OMEGA 3, 6 & 9

On October 4, 2011 by constance

I recommend this to all my patients! Pick up your own capsules or liquid goodness from my Kensington Clinic, The London Wellness Centre.

This particular brand has some very special features that distinguishes it from other fish oil supplements on the market:

1. Is a natural fish oil, which has not been chemically modified

2. Incredibly stable

3. No fishy smell or aftertaste

4. Comes in the convenience of either capsules or liquid

5. Developed by a highly dedicated team of international scientists

6. Is free from environmental contaminants

A recent survey by the Food Safety by the Food Safety Authority of Ireland examined a range of popular European fish oil capsules for the presence of dioxins.  Alarmingly, one of the products tested showed the dioxin level to be five times the maximum limit.

Eskimo-3 stable fish oil was found to have the lowest levels of contaminants, which included dioxins and dioxin-like PCB’s.  Concentration of heavy metal contaminants such as cadmium and mercury was below detection levels in Eskimo-3.

Four capsules of Brainsharp typically contain:

1400mg Omega-3 fatty acids, of which:

600mg   EPA (eicosapentaenoic acid)

400mg   DHA (docosahexaenoic acid)

65mg     ALA (alpha-linolenic acid)

480mg   Omega-6 fatty acids, of which:

400mg   LA (linoleic acid)

45g       GLA (gamma-linolenic acid)

500mg   Omega-9 fatty acids (oleic acid)

4.5mcg     Vitamin D (175iu)

9mg     Vitamin E (15iu)

9mg     CoQ10 (co-enzyme Q10)

Encapsulated with: Ascorbic acid, lecithin, natural lemon oil, gelatin, glycerin.

One 5ml teaspoon of Brainsharp typically contains:

1600mg Omega-3 fatty acids, of which:

700mg   EPA (eicosapentaenoic acid)

450mg   DHA (docosahexaenoic acid)

75mg     ALA (alpha-linolenic acid)

560mg   Omega-6 fatty acids, of which:

400mg   LA (linoleic acid)

50g       GLA (gamma-linolenic acid)

580mg   Omega-9 fatty acids (oleic acid)

5mcg     Vitamin D (175iu)

10mg     Vitamin E (15iu)

10mg     CoQ10 (co-enzyme Q10)

Comments are closed.